05 Mar 2026
Primary Care ‘Undervalued and Underfunded’ Around the World
New research shows that general practice is being relied on more than ever to manage complex health needs, but GPs are underfunded and overworked, with growing administrative pressures.
05 Mar 2026
March 2026 MBS Updates Explained
From 1 March 2026, several changes to the Medicare Benefits Schedule (MBS) have come into effect. These updates include new items, revisions to health assessments, and amendments to existing services to make care more practical and up-to-date.
05 Mar 2026
Medical Colleges Set National Standard for Ethical Billing
All 16 Australian medical colleges have agreed on a national framework to guide ethical and transparent billing.
04 Mar 2026
One GP, Big Impact: Dr Jennie Wright Advocates for General Practice
Dr Jennie Wright, a GP at Adelaide’s Bayside Family Medical and Musculoskeletal Practice, is showing how one GP can make a difference.
04 Mar 2026
Fake GLP-1 Weight-Loss Products Are Still a Danger
The TGA is reminding Australians to be careful with weight-loss products that claim to contain GLP-1 drugs.
04 Mar 2026
Melbourne Researchers Develop Rapid Test for Multiple STIs
Researchers in Melbourne have created a portable test that can detect four common sexually transmitted infections (STIs) in under an hour.
04 Mar 2026
No Plans to Show GP Fees on Medical Costs Website
The Department of Health, Disability and Ageing (DoHDA) says it won’t include individual GP fees on the Medical Costs Finder website, despite new laws mentioning general practice.
03 Mar 2026
GPs Take Patient Rebate Demands to Canberra
GPs have headed to Canberra for the RACGP’s annual GPs@Parliament event, calling for an urgent rise in patient Medicare rebates to make healthcare more affordable.
03 Mar 2026
Recognises Refugee and Migrant Health Expertise
RACGP Fellows can now gain Recognition of Extended Skills (RES) in migrant, refugee and asylum seeker health.
03 Mar 2026
PBS Makes Immunotherapy Cheaper and Easier to Access
From 1 March, Australians can get nivolumab (Opdivo) and ipilimumab (Yervoy) for multiple cancers on the PBS for just $25 per treatment.